longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

JUMPCAN's subsidiary has obtained the drug registration certificate for lidocaine gel patches

Zhitong
Sep 16, 2025 at 08:35 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, JUMPCAN announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. (referred to as "Shaanxi Dongke") has received the drug registration certificate for lidocaine gel patch approved and issued by the National Medical Products Administration. Lidocaine is an amide-type local anesthetic that stabilizes nerve cell membranes by inhibiting the ion channels required for the generation and conduction of nerve impulses

According to the Zhitong Finance APP, JUMPCAN (600566.SH) announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. (referred to as "Shaanxi Dongke") has received the drug registration certificate for lidocaine gel patch approved by the National Medical Products Administration. Lidocaine is an amide-type local anesthetic that stabilizes nerve cell membranes by inhibiting the ion channels required for the generation and conduction of nerve impulses

Login to unlock484characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 10, 2026 at 05:40 AMWorld’s largest contract chipmaker TSMC sees August revenue surge over 53% to record high
JUMPCAN

JUMPCAN

600566.SH

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI